Screener
Vivani Medical VANI Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $4.46M-6.4% | $4.39M+4.1% | $4.63M+7.6% | $4.52M+7.5% | $4.76M+35.5% | ||
| $2.42M-10.5% | $2.43M+3.7% | $2.18M+1.1% | $2.21M+4.7% | $2.7M+24.7% | ||
| $6.87M-7.9% | $6.82M+4.0% | $6.81M+5.4% | $6.73M+6.6% | $7.46M+31.4% | ||
| -$6.87M+7.9% | -$6.82M-4.0% | -$6.81M-5.4% | -$6.73M-6.6% | -$7.46M-31.4% | ||
| -$6.37M+10.8% | -$6.78M-7.6% | -$6.63M-9.6% | -$6.53M-8.1% | -$7.14M-33.4% | ||
| -$0.07+41.7% | -$0.08+27.3% | -$0.09+18.2% | -$0.110.0% | -$0.12-20.0% | ||
| -$6.75M+8.3% | -$6.69M-3.6% | -$6.7M-5.1% | -$6.62M-6.8% | -$7.36M-31.9% | ||
| -$6.87M+7.9% | -$6.82M-4.0% | -$6.81M-5.4% | -$6.73M-6.6% | -$7.46M-31.4% |
FAQ
- Is Vivani Medical profitable?
- Vivani Medical is not currently profitable: it reported a net loss of $26.3M over the trailing twelve months, a -994.1% net margin.
- What are Vivani Medical's profit margins?
- Gross margin is 36.3% and operating margin is -1004.9%, with a -994.1% net margin.
- What is Vivani Medical's earnings per share?
- Vivani Medical's diluted EPS over the trailing twelve months is $-0.35.
- Where does Vivani Medical's income statement data come from?
- Every line is extracted from Vivani Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.